What is the share price of Dev Labtech Venture Ltd (DEVLAB) today?
The share price of DEVLAB as on 22nd October 2026 is ₹24.50. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.What is the return on Dev Labtech Venture Ltd (DEVLAB) share?
The past returns of Dev Labtech Venture Ltd (DEVLAB) share are- Past 1 week: -16.38%
- Past 1 month: 17.11%
- Past 3 months: 45.97%
- Past 6 months: -4.62%
- Past 1 year: 62.49%
- Past 3 years: 57.51%
- Past 5 years: 97.57%
What are the peers or stocks similar to Dev Labtech Venture Ltd (DEVLAB)?
The peers or stocks similar to Dev Labtech Venture Ltd (DEVLAB) include:What is the market cap of Dev Labtech Venture Ltd (DEVLAB) share?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Dev Labtech Venture Ltd (DEVLAB) is ₹153.41 Cr as of 22nd October 2026.What is the 52 week high and low of Dev Labtech Venture Ltd (DEVLAB) share?
The 52-week high of Dev Labtech Venture Ltd (DEVLAB) is ₹33.99 and the 52-week low is ₹13.75.What is the PE and PB ratio of Dev Labtech Venture Ltd (DEVLAB) stock?
The P/E (price-to-earnings) ratio of Dev Labtech Venture Ltd (DEVLAB) is 16.01. The P/B (price-to-book) ratio is 3.01.Which sector does Dev Labtech Venture Ltd (DEVLAB) belong to?
Dev Labtech Venture Ltd (DEVLAB) belongs to the Health Care sector & Hospitals & Diagnostic Centres sub-sector.How to buy Dev Labtech Venture Ltd (DEVLAB) shares?
You can directly buy Dev Labtech Venture Ltd (DEVLAB) shares on Tickertape. Simply sign up, connect your demat account and place your order.
Dev Labtech Venture Ltd
DEVLAB Share Price
BSEDEVLAB Stock Scorecard
Performance
LowHasn't fared well - amongst the low performers
Valuation
HighSeems to be overvalued vs the market average
Growth
LowLagging behind the market in financials growth
Profitability
HighShowing good signs of profitability & efficiency
Entry point
BadThe stock is in the overbought zone
Red flags
LowNo red flag found
How to use scorecard? Learn more
DEVLAB Performance & Key Metrics
DEVLAB Performance & Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| — | 3.01 | — |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 44.18 | 5.54 | 0.51% |
DEVLAB Analyst Ratings & Forecast
Price Upside
Earnings Growth
Rev. Growth
DEVLAB Company Profile
Dev Labtech Venture Limited manufactures polished and lab-grown diamonds using MPCVD technology, serving industries like mining and oil with products such as CVD diamonds for industrial tools.
DEVLAB Forecast
DEVLAB Forecasts
DEVLAB
DEVLAB
Income
Balance Sheet
Cash Flow
DEVLAB Income Statement
DEVLAB Income Statement
DEVLAB Company Updates
DEVLAB Stock Peers
DEVLAB Past Performance & Peer Comparison
DEVLAB Past Performance & Peer Comparison
Health CareHospitals & Diagnostic Centres
Valuation
Technical
Forecast
| Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
|---|---|---|---|
| Dev Labtech Venture Ltd | 16.01 | 3.01 | — |
| Apollo Hospitals Enterprise Limited | 58.43 | 11.37 | 0.25% |
| Manipal Health Enterprises Limited | 94.70 | 9.60 | — |
| Max Healthcare Institute Limited | 57.09 | 7.66 | 0.24% |
DEVLAB Stock Price Comparison
Compare DEVLAB with any stock or ETFDEVLAB Holdings
DEVLAB Shareholdings
DEVLAB Promoter Holdings Trend
DEVLAB Promoter Holdings Trend
DEVLAB Institutional Holdings Trend
DEVLAB Institutional Holdings Trend
No institutional holdings trend are available
DEVLAB Shareholding Pattern
DEVLAB Shareholding Pattern
DEVLAB Shareholding History
DEVLAB Shareholding History
smallcases containing DEVLAB stock
smallcases containing DEVLAB stock
Looks like this stock is not in any smallcase yet.
DEVLAB Events
DEVLAB Events
DEVLAB Dividend Trend
DEVLAB has not given any dividends in last 5 years
Dividends
Corp. Actions
Announcements
Legal Orders
DEVLAB Dividend Trend
DEVLAB has not given any dividends in last 5 years
DEVLAB Dividends
DEVLAB Dividends
DEVLAB Stock News & Opinions
DEVLAB Stock News & Opinions
Dev Labtech Venture Limited informed the BSE Limited that it has received a certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018, for the quarter ended September 30, 2026, from MUFG Intime India Private Limited, formerly Link Intime India Private Limited, its Registrar and Share Transfer Agent (RTA).
Dev Labtech Venture Limited is proceeding with a preferential allotment of warrants, which will be converted into equity shares, with allotment dates yet to be determined pending shareholder approval. The offering involves preferential allotment to Promoter/Director Jerambhai Lavjibhai Donda, Whole-Time Director/CFO Jay Jerambhai Donda (a relative), Director Dimple Jay Donda (also a relative), Practicing Company Secretary Ricky Kapadia, and several non-promoter investors including Sachin Madhusudan Chhatre and Rajendrasinh Hathisinh Sarvaiya. Allottees will pay 25% of the consideration upon warrant allotment and the remaining 75% upon equity share conversion, with any unutilized funds forfeited if conversion doesn't occur within 18 months. The equity shares resulting from the warrant conversion will be listed on the BSE SME Platform and are subject to SEBI lock-in regulations, while a valuation report from Ricky Kapadia was used to determine the warrant price.
Dev Labtech Venture Limited announced a board decision to raise Rs 17.81 crore through the preferential allotment of up to 1,37,00,000 convertible warrants to promoter/promoter group and non-promoter shareholders at a price of Rs 13 per warrant, convertible into equity shares with a face value of Rs 5 each and a premium of Rs 8. The company also approved an increase in its authorized share capital from Rs 25 crore (divided into 5 crore equity shares of Rs 5 each) to Rs 31 crore (divided into 6,20,00,000 equity shares of Rs 5 each). Additionally, the board appointed Ricky Kapadia as the scrutinizer for the upcoming Extraordinary General Meeting (EGM) and fixed October 29, 2026, as the record date for e-voting eligibility.
Dev Labtech Venture Limited increased its authorized share capital from Rs 25 crore divided into 5 crore equity shares of Rs 5 each to Rs 31 crore divided into 6.2 crore equity shares of Rs 5 each. The company also approved the issuance of up to 1.37 crore convertible warrants to promoters, promoter groups, and non-promoters on a preferential basis at a price of Rs 13 each, potentially raising Rs 17.81 crore. Additionally, the board appointed Ricky Kapadia as the scrutinizer for the upcoming Extraordinary General Meeting (EGM), scheduled for November 5, 2026, and fixed October 29, 2026, as the record date for e-voting eligibility.
Dev Labtech Venture Limited said its board approved an increase in the authorized share capital from Rs 25 crore divided into 5 crore shares of Rs 5 each to Rs 31 crore divided into 6.2 crore shares of Rs 5 each. The board also approved the issuance of up to 13.7 million convertible warrants to promoters, promoter groups, and non-promoters on a preferential basis at a price of Rs 13 per warrant, potentially raising Rs 17.81 crore. The company has fixed October 29, 2026, as the record date for determining shareholders eligible to vote at an extraordinary general meeting scheduled for November 5, 2026.
Dev Labtech Venture Limited will hold a board meeting on Wednesday, October 7, 2026, at 3:00 p.m. to consider increasing the company’s authorized share capital and evaluating proposals for raising funds through the issue of equity shares or other convertible securities via a preferential allotment, subject to regulatory approvals. The company has also closed its trading window for insiders and designated persons from October 2, 2026, until 48 hours after the release of undisclosed price-sensitive information.
Dev Labtech Venture Limited informed the BSE Limited that the trading window for dealing in securities of the company will be closed from October 1, 2026, until 48 hours after the declaration of unaudited standalone and consolidated financial results for the half year ended September 30, 2026, in accordance with SEBI regulations.
Dev Labtech Venture Limited has entered into a Master Facility Agreement with HDFC Bank on September 5, 2026, to avail credit facilities of Rs 210.00 lakh for working capital requirements. The facility, an Overdraft Against Property - Manufacturers (ODAP-MFRS), carries an interest rate of 8.9% per annum and has a tenure of 12 months, repayable on demand and subject to annual renewal, with primary security provided as residential and commercial property.
Dev Labtech Venture Limited informed the BSE Limited that its Board of Directors approved the Directors’ Report for the financial year ended March 31, 2026, appointed Mr. Ricky Kapadia of M/s. RPK & Associates as Scrutinizer for the 33rd Annual General Meeting, and appointed National Securities Depository Limited for e-voting platform services, with a record date of September 19, 2026, for determining member eligibility to vote electronically at the 33rd Annual General Meeting scheduled for September 26, 2026, at 1:00 p.m. through video conferencing or other audio-visual means.
Dev Labtech Venture Limited informed the BSE that its board approved availing credit facilities of Rs 2.10 crore from HDFC Bank, and withdrew its earlier decision to strike off Dev Labtech Venture Inc. (USA), a wholly-owned subsidiary, citing present and future business requirements and strategic expansion plans.
In last 6 months, promoter holding in the company has almost stayed constant
Pledged promoter holdings is insignificant